WAZZI-100 Suspension provides Azithromycin 100 mg in a convenient paediatric liquid formulation for selected susceptible bacterial infections. Its once-daily-type convenience, when prescribed appropriately, can support treatment adherence in children. A useful PCD Pharma Paediatric Antibiotic portfolio product.
Selected susceptible bacterial infections.
No.
Use only when prescribed and complete the recommended course. Confirm allergy history and avoid unnecessary antibiotic use.
Diarrhea, nausea, vomiting, abdominal discomfort and headache may occur.
WAZZI-100 Susp: Azithromycin binds to the bacterial 50S ribosomal subunit and inhibits bacterial protein synthesis, suppressing growth of susceptible bacteria.
